Mark Pryor said...

We would double-fill it, which would be an economic issue.

My understanding is there's a new therapy that's in the pipeline that shows some promise.

I have sponsored a bipartisan bill, S. 896, to kind of solve this problem.

And, back to your budget, and looking at the cost to you of implementing this and rolling this out...